期刊文献+

耳廓基底细胞癌应用手术切除并耳后带蒂肌皮瓣一期修复效果观察

Surgical removal and primary repair with pedicle musculocutaneous flap for auricle basal cell carcinoma
下载PDF
导出
摘要 目的 分析耳廓基底细胞癌患者的治疗效果。方法 选取2012年1月至2016年1月本院收治的耳廓基底细胞癌患者24例,在安全缘范围带软骨完整切除,选择耳后乳突上对应缺损组织大小肌皮瓣转移一期修复。术后病理确定切除范围安全,不进行放疗。结果 24例患者术后均一期治愈,转移肌皮瓣修复形态完整,手术痕迹隐蔽。术后随访2年及以上均未见复发。结论 耳廓基底细胞癌掌握安全缘切除可以一期达到治愈效果,避免增加放疗,转移肌皮瓣修复组织缺损最大程度保证了形态美观,且选材方便,达到病理和心理双向治疗,在耳廓肿瘤治疗中医疗优势突出。 Objective To analyze the therapeutic effect of patients with basal cell carcinoma of auricle. Methods 24 patients with auricle basal cell carcinoma were treated by complete resection of cartilage in the area of safe margin and took primary repair with pedicle musculocutaneous flap at our hospital from January, 2012 to January, 2016. Determined by postoperative pathology, the scope of excision was safe, and no radiotherapy was performed. Results All the 24 patients were cured in one stage after operation, with complete repair of metastatic musculocutaneous flap and hidden surgical traces. No recurrence was found during 2 years postoperative followup. Conclusion The safe edge resection of auricle basal cell carcinoma can achieve curative effect in one stage, avoid radiotherapy, and the metastatic musculocutaneous flap can repair the tissue defect to the greatest extent, which guarantees the appearance of beauty, and the material selection is convenient, achieving pathological and psychological bidirectional treatment and highlighting the medical advantages in the treatment of auricle tumor.
作者 喻博 朱旭 任树北 宋文 宁雅萍 Yu Bo;Zhu Xu;Ren Shubei;Song Wen;Ning Yaping(Department of Otolaryngology,Central Hospital of Anshan city,Anshan 114000,China)
出处 《国际医药卫生导报》 2019年第17期2969-2971,共3页 International Medicine and Health Guidance News
关键词 耳廓基底细胞癌 皮下带蒂肌皮瓣 带软骨安全缘切除 Auricle basal cell carcinoma Subcutaneous pedicle musculocutaneous flap Safe margin of cartilage excision
  • 相关文献

参考文献6

二级参考文献41

  • 1李德忠,宋华志,易峰涛,周小煦.氩氦刀冷冻兔肝后局部组织变化及超微病理研究[J].华南国防医学杂志,2006,20(3):4-6. 被引量:9
  • 2Parkin D M,Muir C S.Cancer Incidence in Five Continents.Comparability and quality of data.IARC Sci Publ,1992,120:45-173.
  • 3Thissen M R,Neumann M H,Schouten L J.A systemic review of treatment modalities for primary basal cell carcinomas.Arch Dermatol,1999,135:1177-1183.
  • 4Albert M R,Weinstock M A.Keratinocyte carcinoma.CA Cancer J Clin,2003,53:292-302.
  • 5de Vries E,Louwman M,Bastiaens M,et al.Rapid and continuous increases in incidence rates of basal cell carcinoma in the southeast Netherlands since 1973.J Invest Dermatol,2004,123:634-638.
  • 6Cheng S Y,Luk N M,Chong L Y.Special features of non-melanoma skin cancer in Hong Kong Chinese patients:10-year retrospective study.Hong Kong Med J,2001,7:22-28.
  • 7Rawashdeh M A,Matalka I.Basal cell carcinoma of the maxillofacial region:site distribution and incidence rates in Arab/Jordanians,1991 to 2000.J Oral Maxillofac Surg,2004,62:145-149.
  • 8Tan S H,Tham S N,Goh C L.Skin cancers at Tertiary Referral Skin Hospital in Singapore.Int J Dermatol,1995,34:770-776.
  • 9Miller S J.Etiology and pathogenesis of basal cell carcinoma.Clin Dermatol,1995,13:527-536.
  • 10Snow S N,Sahl W,Lo J S,et al.Metastatic basal cell carcinoma:Report of five cases.Cancer,1994,73:328-335.

共引文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部